BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16524369)

  • 1. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.
    Klejbor I; Myers JM; Hausknecht K; Corso TD; Gambino AS; Morys J; Maher PA; Hard R; Richards J; Stachowiak EK; Stachowiak MK
    J Neurochem; 2006 Jun; 97(5):1243-58. PubMed ID: 16524369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of GABAA receptor subunit variants in midbrain dopaminergic neurons.
    Okada H; Matsushita N; Kobayashi K; Kobayashi K
    J Neurochem; 2004 Apr; 89(1):7-14. PubMed ID: 15030384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection of tyrosine kinase deleted FGF receptor-1 into rat brain substantia nigra reduces the number of tyrosine hydroxylase expressing neurons and decreases concentration levels of striatal dopamine.
    Corso TD; Torres G; Goulah C; Roy I; Gambino AS; Nayda J; Buckley T; Stachowiak EK; Bergey EJ; Pudavar H; Dutta P; Bloom DC; Bowers WJ; Stachowiak MK
    Brain Res Mol Brain Res; 2005 Oct; 139(2):361-6. PubMed ID: 16039006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
    Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
    Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of the midbrain dopaminergic pathways during mouse development.
    Hu Z; Cooper M; Crockett DP; Zhou R
    J Comp Neurol; 2004 Aug; 476(3):301-11. PubMed ID: 15269972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia.
    Galter D; Buervenich S; Carmine A; Anvret M; Olson L
    Neurobiol Dis; 2003 Dec; 14(3):637-47. PubMed ID: 14678778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol.
    Szot P; White SS; Veith RC; Rasmussen DD
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1643-9. PubMed ID: 10549997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene.
    Castillo SO; Baffi JS; Palkovits M; Goldstein DS; Kopin IJ; Witta J; Magnuson MA; Nikodem VM
    Mol Cell Neurosci; 1998 May; 11(1-2):36-46. PubMed ID: 9608532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.
    Grothe C; Timmer M; Scholz T; Winkler C; Nikkhah G; Claus P; Itoh N; Arenas E
    Neurobiol Dis; 2004 Nov; 17(2):163-70. PubMed ID: 15474354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K; Jones SA; Hyman C; Zimmer J
    Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.
    Lessard A; Pickel VM
    Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse.
    John CE; Budygin EA; Mateo Y; Jones SR
    J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.
    Liss B; Haeckel O; Wildmann J; Miki T; Seino S; Roeper J
    Nat Neurosci; 2005 Dec; 8(12):1742-51. PubMed ID: 16299504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the expressions of mRNA for GDNF and its receptors in the ventral midbrain of rats exposed to subchronic phencyclidine.
    Semba J; Akanuma N; Wakuta M; Tanaka N; Suhara T
    Brain Res Mol Brain Res; 2004 Apr; 124(1):88-95. PubMed ID: 15093689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.
    Salvatore MF; Fisher B; Surgener SP; Gerhardt GA; Rouault T
    Brain Res Mol Brain Res; 2005 Oct; 139(2):341-7. PubMed ID: 16051392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
    Mueller HT; Haroutunian V; Davis KL; Meador-Woodruff JH
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):60-9. PubMed ID: 14969737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines.
    Ling ZD; Potter ED; Lipton JW; Carvey PM
    Exp Neurol; 1998 Feb; 149(2):411-23. PubMed ID: 9500954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
    Rothblat DS; Schroeder JA; Schneider JS
    J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.